LLYVK:NASDAQLiberty Live Holdings, Inc. - Series C Liberty Live Group Analysis
Data as of 2026-05-19 - not real-time
$96.42
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Liberty Live Holdings trades at $96.42, comfortably above its 20‑day ($95.47) and 50‑day ($95.59) moving averages, and the bullish MACD (line $0.89 above signal $0.57) signals short‑term momentum. The RSI sits at a neutral 50.3 and volume is on an upward trend, while the stock sits midway between a support level of $90.55 and resistance near $101.83, suggesting room for upside. Revenue growth is strong at 35% YoY, yet profitability is weak—gross margin is only 20%, operating margin is –26%, and trailing EPS is –$3.83, resulting in negative PE and PB multiples. The balance sheet shows $1.82 B of debt against $524 M of cash, and a negative book value per share ($‑3.45), flagging financial risk. Despite these fundamentals, market sentiment is highly positive (Fear‑Greed Index 89 – “Extreme Greed”) and analysts project a target price of $115, implying a 19% upside.
Investors should weigh the technical bullishness and growth narrative against the heavy debt load, negative earnings, and high 30‑day volatility (33%) before deciding on position size.
Investors should weigh the technical bullishness and growth narrative against the heavy debt load, negative earnings, and high 30‑day volatility (33%) before deciding on position size.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and price above short‑term SMAs
- Increasing volume indicating buying interest
- Proximity to support level provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth (35% YoY) and analyst target price of $115
- Technical upside to resistance at $101.83
- Market sentiment in extreme greed phase supporting price rally
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt burden and negative equity raise solvency concerns
- Sustained negative earnings and cash flow
- Potential for turnaround if operating margins improve
Key Metrics & Analysis
Financial Health
Revenue Growth35.20%
Profit Margin-88.23%
P/E Ratio-33.7
ROA-2.05%
P/B Ratio-27.9
Op. Cash Flow$-21615000
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI50.3
Support$90.55
Resistance$101.83
MA 20$95.47
MA 50$95.59
MA 200$90.78
MACDBullish
VolumeIncreasing
Fear & Greed Index89.18
Valuation
Target Price$115.00
Upside/Downside19.27%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.83
Volatility33.40%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.